|
May 6
|
UPDATE 1-Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
|
|
May 6
|
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
|
|
May 6
|
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
|
|
May 6
|
Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key
|
|
May 6
|
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
|
|
May 6
|
Vertex Reports First Quarter 2024 Financial Results
|
|
May 6
|
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
|
|
May 5
|
3 No-Brainer Stocks to Buy in May
|
|
May 4
|
23 Most Profitable Stocks of the Last 12 Months
|
|
May 3
|
Insider Sale at Vertex Pharmaceuticals Inc (VRTX): Director Sangeeta Bhatia Sells Shares
|
|
May 2
|
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
|
|
May 1
|
Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know
|
|
May 1
|
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Apr 30
|
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?
|
|
Apr 29
|
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
|
|
Apr 28
|
2 Top Growth Stocks to Buy Right Now and Hold Forever
|
|
Apr 27
|
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.
|
|
Apr 26
|
Pioneer Institute study finds IRA discourages non-opioid drug innovation
|
|
Apr 26
|
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
|
|
Apr 26
|
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
|